Benbo Zheng1, Rongce Zhao2, Xiaodong Li1, Bo Li3. 1. Department of Hepatobiliary and Pancreatic Surgery, The People's Hospital of Deyang, Deyang, 618000, Sichuan, China. 2. Department of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, No. 37 Guoxuexiang, Chengdu, 610041, Sichuan Province, China. zhaorongce@163.com. 3. Department of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, No. 37 Guoxuexiang, Chengdu, 610041, Sichuan Province, China. cdlibo168@hotmail.com.
Abstract
BACKGROUND: Laparoscopic liver resection (LLR) is mostly performed to treat benign lesions at easily accessible locations. With improvements in instruments and accumulation of experience, LLR has evolved to treat malignant tumors with major hepatectomy, even in less accessible locations, without compromising the principles of safety and oncology. The present meta-analysis aimed to compare the outcomes of LLR for lesions located in anterolateral (AL) (II, III, IVb, V, and VI) and posterosuperior (PS) (I, IVa, VII, and VIII) liver segments. METHODS: A comprehensive search was conducted to identify all eligible studies. This meta-analysis was performed using the STATA 12.0 statistical software. Standardized mean differences (SMDs) and odds ratios (ORs) were calculated for continuous variables and dichotomous variables, respectively, with 95% confidence intervals (CIs). RESULTS: A total of 846 patients from five studies were identified for the final analysis, with 565 patients in the AL group and 281 in the PS group. Although the operation time (SMD -0.60; 95% CI -0.75 to -0.45; P = 0.000) and conversion rate (OR 0.40; 95% CI 0.24-0.67; P = 0.000) were lower and the resection margin was wider (SMD 0.2; 95% CI 0.03-0.37; P = 0.019) in the AL group than in the PS group, no significant differences in blood loss (SMD -0.29; 95% CI -0.68 to 0.09; P = 0.131), complication rate (OR 0.73; 95% CI 0.50-1.07; P = 0.103), hospital stay (SMD -0.53; 95% CI -1.16 to 0.11; P = 0.105), and tumor recurrence (OR 1.23; 95% CI 0.81-1.86; P = 0.334) were noted between the groups. CONCLUSION: LLR is technically feasible and safe for selected patients with lesions in the PS segments of the liver.
BACKGROUND: Laparoscopic liver resection (LLR) is mostly performed to treat benign lesions at easily accessible locations. With improvements in instruments and accumulation of experience, LLR has evolved to treat malignant tumors with major hepatectomy, even in less accessible locations, without compromising the principles of safety and oncology. The present meta-analysis aimed to compare the outcomes of LLR for lesions located in anterolateral (AL) (II, III, IVb, V, and VI) and posterosuperior (PS) (I, IVa, VII, and VIII) liver segments. METHODS: A comprehensive search was conducted to identify all eligible studies. This meta-analysis was performed using the STATA 12.0 statistical software. Standardized mean differences (SMDs) and odds ratios (ORs) were calculated for continuous variables and dichotomous variables, respectively, with 95% confidence intervals (CIs). RESULTS: A total of 846 patients from five studies were identified for the final analysis, with 565 patients in the AL group and 281 in the PS group. Although the operation time (SMD -0.60; 95% CI -0.75 to -0.45; P = 0.000) and conversion rate (OR 0.40; 95% CI 0.24-0.67; P = 0.000) were lower and the resection margin was wider (SMD 0.2; 95% CI 0.03-0.37; P = 0.019) in the AL group than in the PS group, no significant differences in blood loss (SMD -0.29; 95% CI -0.68 to 0.09; P = 0.131), complication rate (OR 0.73; 95% CI 0.50-1.07; P = 0.103), hospital stay (SMD -0.53; 95% CI -1.16 to 0.11; P = 0.105), and tumor recurrence (OR 1.23; 95% CI 0.81-1.86; P = 0.334) were noted between the groups. CONCLUSION: LLR is technically feasible and safe for selected patients with lesions in the PS segments of the liver.
Authors: Ibrahim Dagher; Brice Gayet; Dimitrios Tzanis; Hadrien Tranchart; David Fuks; Olivier Soubrane; Ho-Seong Han; Ki-Hun Kim; Daniel Cherqui; Nicholas O'Rourke; Roberto I Troisi; Luca Aldrighetti; Edwin Bjorn; Mohammed Abu Hilal; Giulio Belli; Hironori Kaneko; William R Jarnagin; Charles Lin; Juan Pekolj; Joseph F Buell; Go Wakabayashi Journal: J Hepatobiliary Pancreat Sci Date: 2014-08-06 Impact factor: 7.027
Authors: Jin Yao Teo; Juinn Huar Kam; Chung Yip Chan; Brian K P Goh; Jen-San Wong; Victor T W Lee; Peng Chung Cheow; Pierce K H Chow; London L P J Ooi; Alexander Y F Chung; Ser Yee Lee Journal: Hepatobiliary Surg Nutr Date: 2015-12 Impact factor: 7.293
Authors: Joseph F Buell; Daniel Cherqui; David A Geller; Nicholas O'Rourke; David Iannitti; Ibrahim Dagher; Alan J Koffron; Mark Thomas; Brice Gayet; Ho Seong Han; Go Wakabayashi; Giulio Belli; Hironori Kaneko; Chen-Guo Ker; Olivier Scatton; Alexis Laurent; Eddie K Abdalla; Prosanto Chaudhury; Erik Dutson; Clark Gamblin; Michael D'Angelica; David Nagorney; Giuliano Testa; Daniel Labow; Derrik Manas; Ronnie T Poon; Heidi Nelson; Robert Martin; Bryan Clary; Wright C Pinson; John Martinie; Jean-Nicolas Vauthey; Robert Goldstein; Sasan Roayaie; David Barlet; Joseph Espat; Michael Abecassis; Myrddin Rees; Yuman Fong; Kelly M McMasters; Christoph Broelsch; Ron Busuttil; Jacques Belghiti; Steven Strasberg; Ravi S Chari Journal: Ann Surg Date: 2009-11 Impact factor: 12.969